Swiss stocks - Factors to watch on Dec. 7 [Reuters]
Novartis AG (NVS)
Last novartis ag earnings: 4/28 01:00 am
Check Earnings Report
US:NYSE Investor Relations:
novartis.com/investors
Company Research
Source: Reuters
Swiss stocks - Factors to watch on Dec. 7 | Reuters 1 Min Read ZURICH/BERLIN, Dec 7 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Friday: The drugmaker said its U.S. unit Sandoz Inc. will launch Adamis Pharmaceuticals Corp’s emergency allergy shots next year in the United States, at a price that is about 16 percent below that of similar rival products. The drugmaker said that its Tecentriq immunotherapy in combination with chemotherapy was approved by the U.S. Food and Drug Administration as a first-line treatment for a type of lung cancer. Meyer Burger’s largest shareholder called for the money-losing solar machinery maker to renew its board of directors and to consider raising money to finance its own efforts to manufacture solar cells. * Landis+Gyr announced a series of project and contract updates involving metering deployments at Evergy Inc. subsidiaries. No major economic data scheduled. (Reporting by Zurich newsroom and Berlin Speed Desk) All qu
Show less
Read more
Impact Snapshot
Event Time:
NVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVS alerts
High impacting Novartis AG news events
Weekly update
A roundup of the hottest topics
NVS
News
- Global $20B+ Macular Degeneration Treatment Market Outlook, 2024-2029: AI Integration Paves the Way for Personalized Care [Yahoo! Finance]Yahoo! Finance
- Dyno Therapeutics Unveils Path to Exponentially Reducing the Cost of In Vivo Gene Delivery at the 2024 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting [Yahoo! Finance]Yahoo! Finance
- Dyno Therapeutics to Accelerate Design of High-Performance Biological Sequences Using NVIDIA AI [Yahoo! Finance]Yahoo! Finance
- Axmed raises $2M from Founderful to streamline drug supply chains in underserved markets [Yahoo! Finance]Yahoo! Finance
- Axmed raises $2M from Founderful to streamline drug supply chains in underserved markets [TechCrunch]TechCrunch
NVS
Earnings
- 4/23/24 - Beat
NVS
Sec Filings
- 4/23/24 - Form 6-K
- 2/15/24 - Form S-8
- NVS's page on the SEC website